相关实验视频

Updated: Jul 9, 2026

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

Published on: October 24, 2019

-225放射性药物的质量控制:马来西亚当前的挑战和解决方案

Z Ashhar¹, M F Fadzil², M A Said³

¹Sabah Women and Children Hospital, Nuclear Medicine Department, Locked Bag No. 187, Kota Kinabalu, Sabah, Malaysia.

The Medical journal of Malaysia

|November 30, 2024

概括

新的α-放射性核素疗法对转移性割抵抗性前列腺癌 (mCRPC) 有前途. 然而, [225Ac] 动

科学领域:

核医学和瘤学的核医学和瘤学.
放射性药物疗法是一种放射性药物疗法.

背景情况:

针对前列腺特异性膜抗原 (PSMA) 的放射性药物已经彻底改变了转移性割抵抗性前列腺癌 (mCRPC) 治疗.
标记为PSMA放射性体疗法 (RLT) 的actinium-225 ([225Ac]) 证明了mCRPC管理中的有效性和安全性.
[225Ac]Actinium的核反弹可能会导致子放射性核素的释放,可能导致目标器官外辐射和功能障碍.

研究的目的:

为了应对与PSMA-RLT中的 [225Ac]Actinium核反弹相关的挑战.
介绍马来西亚PSMA-RLT的现状.
通过基于风险的方法,提出内部准备的解决方案.

主要方法:

审查马来西亚目前针对PSMA的放射性药品的情况.
分析与 [225Ac]Actinium 核反弹相关的风险.
开发一种基于风险的方法,用于内部制备 [225Ac]Ac-PSMA-RLT.

主要成果:

马来西亚关于使用 [225Ac]Ac-PSMA-RLT 的挑战的识别.
一个基于风险的分析框架,以减轻核反弹可能带来的不利影响.
关于在公司内部安全有效地制备 [225Ac]Ac-PSMA-RLT 的建议策略.

结论:

虽然[225Ac]Ac-PSMA-RLT为mCRPC提供了显著的治疗潜力,但管理核反弹效应至关重要.
实施基于风险的内部制备方法可以提高安全性和有效性.
需要进一步的研究和标准化的协议来优化马来西亚的 [225Ac]Ac-PSMA-RLT.

更多相关视频

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

An Automated Radiosynthesis of [⁶⁸Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

相关概念视频

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Pharmaceutical Poisoning: Treatment Strategies

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...